DOPHALINE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DOPHALINE
Largest movements
- Receivables within one year +€341,980
up €341,980 (+11.6%), from €2.9m to €3.3m
of which Trade receivables: +€372,326
- Stocks and contracts +€78,220
up €78,220 (+13.7%), from €571,375 to €649,595
- Profit (loss) carried forward +€553,077
up €553,077 (+22.3%), from €2.5m to €3.0m
- Debts after one year -€190,000
down €190,000 (-39.6%), from €480,000 to €290,000
- Other debts +€172,339
up €172,339 (+47.1%), from €365,909 to €538,248
- Trade debts -€91,306
down €91,306 (-12.9%), from €707,337 to €616,031
- Gross operating margin +€591,228
up €591,228 (+78.4%), from €754,047 to €1.3m
- Taxes +€136,856
up €136,856 (+110.2%), from €124,146 to €261,002
- Depreciation +€52,659
up €52,659 (+82.8%), from €63,593 to €116,252
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,191,041 | €4,641,211 | +€450,170 | +10.7% |
| Fixed assets | 21/28 | €392,341 | €395,360 | +€3,019 | +0.8% |
| Tangible fixed assets | 22/27 | €392,229 | €395,248 | +€3,019 | +0.8% |
| Plant, machinery and equipment | 23 | €2,798 | €1,436 | -€1,362 | -48.7% |
| Furniture and vehicles | 24 | €389,432 | €393,812 | +€4,380 | +1.1% |
| Financial fixed assets | 28 | €112 | €112 | = | 0.0% |
| Current assets | 29/58 | €3,798,700 | €4,245,851 | +€447,151 | +11.8% |
| Stocks and contracts in progress | 3 | €571,375 | €649,595 | +€78,220 | +13.7% |
| Stocks | 30/36 | €571,375 | €649,595 | +€78,220 | +13.7% |
| Amounts receivable within one year | 40/41 | €2,937,918 | €3,279,898 | +€341,980 | +11.6% |
| Trade receivables | 40 | €2,759,616 | €3,131,942 | +€372,326 | +13.5% |
| Other amounts receivable | 41 | €178,301 | €147,955 | -€30,346 | -17.0% |
| Cash at bank and in hand | 54/58 | €277,801 | €297,811 | +€20,010 | +7.2% |
| Deferred charges and accrued income | 490/1 | €11,606 | €18,548 | +€6,941 | +59.8% |
| Total equity and liabilities | 10/49 | €4,191,041 | €4,641,211 | +€450,170 | +10.7% |
| Equity | 10/15 | €2,597,346 | €3,150,423 | +€553,077 | +21.3% |
| Contributions | 10/11 | €105,000 | €105,000 | = | 0.0% |
| Reserves | 13 | €10,500 | €10,500 | = | 0.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €10,500 | €10,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €2,481,846 | €3,034,923 | +€553,077 | +22.3% |
| Amounts payable | 17/49 | €1,593,695 | €1,490,787 | -€102,907 | -6.5% |
| Amounts payable after more than one year | 17 | €480,000 | €290,000 | -€190,000 | -39.6% |
| Other amounts payable | 178/9 | €480,000 | €290,000 | -€190,000 | -39.6% |
| Amounts payable within one year | 42/48 | €1,105,394 | €1,200,787 | +€95,394 | +8.6% |
| Trade debts | 44 | €707,337 | €616,031 | -€91,306 | -12.9% |
| Suppliers | 440/4 | €707,337 | €616,031 | -€91,306 | -12.9% |
| Taxes, remuneration and social security | 45 | €32,148 | €46,508 | +€14,361 | +44.7% |
| Taxes | 450/3 | €4,342 | €15,343 | +€11,001 | +253.3% |
| Remuneration and social security | 454/9 | €27,806 | €31,165 | +€3,360 | +12.1% |
| Other amounts payable | 47/48 | €365,909 | €538,248 | +€172,339 | +47.1% |
| Accrued charges and deferred income | 492/3 | €8,301 | €0 | -€8,301 | -100.0% |
| Non-recurring operating income | 76A | €51,639 | €18,514 | -€33,125 | -64.1% |
| Remuneration, social security and pensions | 62 | €163,570 | €166,170 | +€2,600 | +1.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €63,593 | €116,252 | +€52,659 | +82.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€10,945 | €1,685 | +€12,630 | |
| Other operating charges | 640/8 | €15,055 | €12,430 | -€2,626 | -17.4% |
| Non-recurring operating charges | 66A | €6,662 | €0 | -€6,662 | -100.0% |
| Gross operating margin | 9900 | €754,047 | €1,345,276 | +€591,228 | +78.4% |
| Operating profit (loss) | 9901 | €516,112 | €1,048,740 | +€532,628 | +103.2% |
| Financial income | 75/76B | €59 | €50 | -€9 | -15.9% |
| Recurring financial income | 75 | €59 | €50 | -€9 | -15.9% |
| Financial charges | 65/66B | €31,633 | €33,111 | +€1,478 | +4.7% |
| Recurring financial charges | 65 | €31,633 | €33,111 | +€1,478 | +4.7% |
| Profit (loss) for the period before taxes | 9903 | €484,538 | €1,015,679 | +€531,141 | +109.6% |
| Income taxes | 67/77 | €124,146 | €261,002 | +€136,856 | +110.2% |
| Profit (loss) for the period | 9904 | €360,392 | €754,677 | +€394,285 | +109.4% |
| Profit (loss) for the period to be appropriated | 9905 | €360,392 | €754,677 | +€394,285 | +109.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.